Aripiprazole induced hypersexuality in a 24-year-old female patient with schizoaffective disorder?

Journal of Clinical Psychopharmacology

Volumn 28, Issue 5, 2008, Pages 567-568

  Schlachetzki, Johannes C M ^a   Langosch, Jens M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CHLORPROTHIXENE; CITALOPRAM; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; AUDITORY HALLUCINATION; CASE REPORT; DOPAMINERGIC SYSTEM; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERSEXUALITY; LETTER; MAJOR DEPRESSION; NEUROBIOLOGY; PERSECUTORY DELUSION; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SEROTONINERGIC SYSTEM; SEXUAL FUNCTION; SIDE EFFECT; SYMPTOMATOLOGY; WEIGHT GAIN; CHEMICALLY INDUCED DISORDER; FOLLOW UP; LIBIDO; SCHIZOPHRENIA; SEXUAL DYSFUNCTION;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIBIDO; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 58149109326     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31818582de     Document Type: Letter

References (17)

1. Dossenbach M, Hodge A, Anders M, et al. Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int JNeuropsychopharmacol. 2005;8:195-201.
2. Argiolas A, Melis MR. The neurophysiology of the sexual cycle. J Endocrinol Invest. 2003; 26:20-22.
3. Kelley AE, Berridge KC. The neuroscience of natural rewards: relevance to addictive drugs. JNeurosci. 2002;22:3306-3311.
4. Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry. 2005;59:1151-1159.
5. Bancroft J. The endocrinology of sexual arousal. J Endocrinology. 2005;186:411-427.
6. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry. 2000; 57:1012-1030.
7. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol. 2007;64:1089-1096.
8. Uçok A, Incesu C, Aker T, et al. Sexual dysfunction in patients with schizophrenia on antipsychotic medication. Eur Psychiatry. 2007;22:328-333.
9. Menon A, Williams RH, Watson S. Increased libido associated with quetiapine. J Psycho- pharmacol. 2006;20:125-127.
10. Arzneimittelkommission der deutschen Ärzteschaft. Hypersexualitat unter Aripiprazole (Abilify). Deutsches Ärzteblatt. 2006;103:3518.
11. Lam MH, Fong SY, Wing YK. Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine. Psychiatry Clin Neurosci. 2007;61:333.
12. Lieberman JA. Dopamine partial agonists: a new class of antipsychotic. CNS Drugs. 2004; 18:251-267.
13. Carlsson A. Antipsychotic drugs, neurotrans- mitters, and schizophrenia. Am J Psychiatry. 1978;135:165-173.
14. Gründer G, Kungel M, Ebrecht M, et al. Aripiprazole: pharmacodynamics of a dopa- mine partial agonist for the treatment of schizophrenia. Pharmacopsychiatry. 2006;39: S21-S25.
15. Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer anti- depressants. JClin Psychiatry. 2002;63:357-366.
16. Wood M, Reavill C. Aripiprazole acts as a selective dopamine D2 receptor partial agonist. Expert Opin Investig Drugs. 2007;16: 771-775.
17. Smith S. Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice. J Clin Psychopharmacol. 2003;23:S27-S32.